Opsoclonus-myoclonus syndrome
MONDO:0015247Opsoclonus myoclonus syndrome (OMS) is a rare neuroinflammatory disease of paraneoplastic, parainfectious or idiopathic origin, characterized by opsoclonus, myoclonus, ataxia, and behavioral and sleep disorders.
Also known as: Ataxo-opso-myoclonus syndrome, Kinsbourne syndrome, OMS, Opsoclonus-Myoclonus-Ataxia Syndrome, POMA syndrome, dancing eye syndrome, dancing eye-dancing feet syndrome, oma syndrome
13 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Could a stem cell transplant stop the immune system from attacking the brain?
Disease control OngoingThis phase 2 trial tests whether high-dose chemotherapy followed by a stem cell transplant can stop the immune system from attacking the nervous system in people with autoimmune neurologic diseases like multiple sclerosis and stiff person syndrome. The treatment aims to weaken th…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can Full-Body scans spot cancer early in High-Risk families?
Diagnosis OngoingThis study is testing whether whole body MRI scans can help find cancers early in children and adults with Li-Fraumeni syndrome, a genetic condition that greatly raises cancer risk. About 150 participants will receive annual whole body MRI scans for four years to see if they keep…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC